Document Detail


Managing patients after myocardial infarction.
MedLine Citation:
PMID:  1968904     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Thrombolytic therapy clearly saves lives when administered in the first critical hours after acute MI. Consequently, most patients can now be treated initially at the community hospital level. Transfer to a tertiary center may be reserved for those who become symptomatic after thrombolysis, which, of course, is not a panacea. Reducing the risks of reinfarction and death remain major issues.
Authors:
L S Cohen
Related Documents :
8544674 - Comparison of "accelerated" tissue plasminogen activator with streptokinase for treatme...
10983734 - A review of the long term effects of thrombolytic agents.
9651794 - The "door-to-needle blitz" in acute myocardial infarction: the impact of a cqi project.
12635684 - Intraocular hemorrhage after systemic thrombolytic therapy in a patient with exudative ...
19632524 - Rationale and design of assessment of lipophilic vs. hydrophilic statin therapy in acut...
10451234 - Characteristics of intracardiac potentials at successful ablation sites in concealed wo...
Publication Detail:
Type:  Clinical Trial; Journal Article; Review    
Journal Detail:
Title:  Hospital practice (Office ed.)     Volume:  25     ISSN:  8750-2836     ISO Abbreviation:  Hosp. Pract. (Off. Ed.)     Publication Date:  1990 Mar 
Date Detail:
Created Date:  1990-04-13     Completed Date:  1990-04-13     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8404149     Medline TA:  Hosp Pract (Off Ed)     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  49-60     Citation Subset:  AIM; IM    
Affiliation:
Yale University.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use
Aged
Angioplasty, Transluminal, Percutaneous Coronary
Aspirin / therapeutic use
Calcium Channel Blockers / therapeutic use
Clinical Trials as Topic
Heart Function Tests
Humans
Myocardial Infarction / rehabilitation,  therapy*
Streptokinase / administration & dosage,  therapeutic use
Thrombolytic Therapy*
Tissue Plasminogen Activator / therapeutic use
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Calcium Channel Blockers; 50-78-2/Aspirin; EC 3.4.-/Streptokinase; EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Epidermal G1-chalone and transforming growth factor-beta are two different endogenous inhibitors of ...
Next Document:  Activated peripheral blood mononuclear cells detected by murine monoclonal antibodies to proliferati...